@article {3214,
	title = {Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients.},
	journal = {Journal of acquired immune deficiency syndromes (1999)},
	volume = {56 Suppl 1},
	year = {2011},
	month = {2011 Mar 1},
	pages = {S62-7},
	abstract = {The safety of buprenorphine/naloxone (bup/nx) in HIV-infected patients has not been established. Prior reports raise concern about hepatotoxicity and interactions with atazanavir.},
	keywords = {Anti-HIV Agents, Buprenorphine, Cohort Studies, Dose-Response Relationship, Drug, Drug Interactions, Drug-Induced Liver Injury, HIV Infections, Humans, Naloxone, Oligopeptides, Opioid-Related Disorders, Pyridines},
	issn = {1944-7884},
	doi = {10.1182/blood-2011-06-362194},
	author = {Vergara-Rodriguez, Pamela and Tozzi, Mary Jo and Botsko, Michael and Nandi, Vijay and Altice, Frederick and Egan, James E and O{\textquoteright}Connor, Patrick G and Sullivan, Lynn E and Fiellin, David A}
}
